ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

ClinicalTrials.gov ID: NCT06425159

Public ClinicalTrials.gov record NCT06425159. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 as Adjunctive Therapy in Subjects With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures, With Open-label Extension

Study identification

NCT ID
NCT06425159
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Biohaven Therapeutics Ltd.
Industry
Enrollment
27 participants

Conditions and interventions

Interventions

  • BHV-7000 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 19, 2024
Primary completion
Mar 11, 2026
Completion
Mar 11, 2026
Last update posted
Mar 23, 2026

2024 – 2026

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
37
Facility City State ZIP Site status
Accel Research Birmingham Alabama 35244
Barrow Neurological Institute Phoenix Arizona 85013
ARENSIA Exploratory Medicine Phoenix Arizona 85015
Center for Neurosciences Tucson Arizona 85718
Profound Research LLC Pasadena California 91105
Medstar Health Research Institute Washington D.C. District of Columbia 20010
Nova Clinical Research, LLC Bradenton Florida 34209
University of Florida (Jacksonville) Jacksonville Florida 32209
Y&L Advance Health Care,Inc d/b/a Elite Clinical Research Miami Florida 33144
Serenity Research Center Miami Florida 33176
Research Institute of Orlando Orlando Florida 32806
Comprehensive Neurology Clinic Orlando Florida 32825
Knight Neurology Rockledge Florida 32955
Santos Research Center Tampa Florida 33615
Encore Medical Research of Weston LLC. Weston Florida 33331
Augusta University Augusta Georgia 30912
Hawaii Pacific Neuroscience Honolulu Hawaii 96817
Consultants in Epilepsy & Neurology, PLLC (CEN) Boise Idaho 83702
Northwestern Medical Group, Department of Neurology Chicago Illinois 60611
Revive Research Institute, Inc. Elgin Illinois 60123
Bluegrass Epilepsy Research Lexington Kentucky 40504
OLOLRMC Baton Rouge Louisiana 70808
University Medical Center New Orleans New Orleans Louisiana 70112
Boston Clinical Trials Boston Massachusetts 02131
Somnos Clinical Research Lincoln Nebraska 68510
NEREG Hackensack New Jersey 07601
Institute of Neurology and Neurosurgery Livingston New Jersey 07039
Dent Neurosciences Research Center Amherst New York 14226
Boston Children's Health Physicians (BCHP) Hawthorne New York 10532-1528
Northwell Health Pediatric Neurology New Hyde Park New York 11042
NYU Langone Health New York New York 10016
Montefiore Medical Center The Bronx New York 10467
UPMC Pittsburgh Pennsylvania 15213
WR-ClinSearch Chattanooga Tennessee 37421
Vanderbilt University Medical Center Nashville Tennessee 37232
Neurology Consultants of Dallas, PA Dallas Texas 75243
ANESC Research El Paso Texas 79912
Road Runner Research, Ltd San Antonio Texas 78249
Intermountain Health Murray Utah 84107
Henrico Doctors' Neurology Associates, LLC Richmond Virginia 23235

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06425159, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06425159 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →